https://specialty.mims.com/topic/fracture-risk-not-higher-with-sglt2-vs-dpp4-inhibitors
0
0
The use of sodium-glucose transporter 2 (SGLT2) inhibitors among patients with diabetes does not pose an increased risk of developing fractures as com...
Create an account
or login to join the discussion